PATENT CLAIM ANALYSIS

Application Number: 16180612
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["549", "029000"]

Abstract:
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) and Formula (II) as follows: wherein Y, R 1 , G, and Q are defined herein;and  wherein R 11 , R 21 , R 41 , R B1  and G 1 , are defined herein.

Claim (Index 30):
A compound of Formula (II) wherein\n R 11  is selected from the group consisting of hydrogen, fluoro, and chloro; \n R B1  is one to four substituents independently selected from the group consisting of fluoro and methyl; \n R 21  is hydroxymethyl or carboxy; \n R 41  is hydrogen or methyl; \n G 1  is chloro or 4-(R A1 )phenyl, wherein R A1  is selected from the group consisting of C 1-2 alkyl and chloro; \n or an enantiomer, diastereomer, or pharmaceutically acceptable salt form thereof.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 98.0
- Lexical Diversity: 1.7619
- Patent Class: 549.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14200108', '14200127', '14200097', '14200114', '15228042']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8431904088866944
- 35 USC 102 Novelty (BERT): 0.6792655363733258
- Combined Prediction Score: 0.8267979216353576
- Mean Citation Score: 547.1481980000002
- Max Citation Score: 687.37866
- Similarity Product: 683.7061869527579

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test